MERCK Kommanditgesellschaft auf Aktien Stock Other OTC
Equities
MKKGY
US5893392093
Pharmaceuticals
Sales 2024 * | 21.32B 22.79B 31.22B | Sales 2025 * | 22.64B 24.19B 33.15B | Capitalization | 67.61B 72.24B 99B |
---|---|---|---|---|---|
Net income 2024 * | 2.99B 3.2B 4.38B | Net income 2025 * | 3.52B 3.77B 5.16B | EV / Sales 2024 * | 3.47 x |
Net Debt 2024 * | 6.38B 6.82B 9.35B | Net Debt 2025 * | 4.56B 4.88B 6.68B | EV / Sales 2025 * | 3.19 x |
P/E ratio 2024 * |
22.6
x | P/E ratio 2025 * |
19.1
x | Employees | - |
Yield 2024 * |
1.5% | Yield 2025 * |
1.64% | Free-Float | 29.71% |
Latest transcript on MERCK Kommanditgesellschaft auf Aktien
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 62 | 20-07-12 | |
Marcus Kuhnert
DFI | Director of Finance/CFO | 56 | 14-07-31 |
Director of Finance/CFO | 54 | 19-04-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 75 | 14-05-08 | |
Chairman | 67 | 19-04-25 | |
Jürgen Glaser
BRD | Director/Board Member | 61 | 12-04-30 |
1st Jan change | Capi. | |
---|---|---|
+14.68% | 9.11B | |
-23.31% | 4.44B | |
+15.70% | 4.24B | |
+32.83% | 4.03B | |
+9.37% | 2.14B | |
+9.30% | 1.94B | |
-33.37% | 1.9B | |
-0.50% | 1.64B | |
-46.20% | 1.63B |